Can therapeutic vaccines against EBV prevent MS in high-risk cohorts?

Therapeutic vaccines targeting Epstein-Barr virus (EBV) hold promising potential to prevent multiple sclerosis (MS) in individuals at high risk, though this approach is still under active research and development. EBV is a common herpesvirus that infects most people worldwide and…








